Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
University of Southern California CRS
mi
from
Los Angeles, CA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
University of Southern California CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Stanford AIDS Clinical Trials Unit CRS
mi
from
Palo Alto, CA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Stanford AIDS Clinical Trials Unit CRS
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Harbor-UCLA CRS
mi
from
Torrance, CA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Harbor-UCLA CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
University of Colorado Hospital CRS
mi
from
Aurora, CO
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Georgetown University CRS (GU CRS)
mi
from
Washington,
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Georgetown University CRS (GU CRS)
mi
from
Washington,
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
The University of Miami AIDS Clinical Research Unit (ACRU) CRS
mi
from
Miami, FL
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
The University of Miami AIDS Clinical Research Unit (ACRU) CRS
mi
from
Miami, FL
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Univ. of Hawaii at Manoa, Leahi Hosp.
mi
from
Honolulu, HI
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Univ. of Hawaii at Manoa, Leahi Hosp.
mi
from
Honolulu, HI
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Cook County Hosp. CORE Ctr.
mi
from
Chicago, IL
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Cook County Hosp. CORE Ctr.
mi
from
Chicago, IL
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Rush University CRS
mi
from
Chicago, IL
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Rush University CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
mi
from
Indianapolis, IN
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Johns Hopkins University CRS
mi
from
Baltimore, MD
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Johns Hopkins University CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Bmc Actg Crs
mi
from
Boston, MA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Bmc Actg Crs
mi
from
Boston, MA
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Washington University Therapeutics (WT) CRS
mi
from
St. Louis, MO
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Washington University Therapeutics (WT) CRS
mi
from
St. Louis, MO
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Beth Israel Med. Ctr. ACTU
mi
from
New York, NY
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Beth Israel Med. Ctr. ACTU
mi
from
New York, NY
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Columbia P&S CRS
mi
from
New York, NY
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Columbia P&S CRS
mi
from
New York, NY
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Chapel Hill CRS
mi
from
Chapel Hill, NC
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Chapel Hill CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Cincinnati CRS
mi
from
Cincinnati, OH
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
MetroHealth CRS
mi
from
Cleveland, OH
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
MetroHealth CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Ohio State University CRS
mi
from
Columbus, OH
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Ohio State University CRS
mi
from
Columbus, OH
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Penn Therapeutics Crs
mi
from
Philadelphia, PA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Penn Therapeutics Crs
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
University of Pittsburgh CRS
mi
from
Pittsburgh, PA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
University of Pittsburgh CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Univ. of Texas Medical Branch, ACTU
mi
from
Galveston, TX
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Univ. of Texas Medical Branch, ACTU
mi
from
Galveston, TX
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
University of Washington AIDS CRS
mi
from
Seattle, WA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
University of Washington AIDS CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated:  12/2/2015
Puerto Rico AIDS Clinical Trials Unit CRS
mi
from
San Juan,
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women
Status: Enrolling
Updated: 12/2/2015
Puerto Rico AIDS Clinical Trials Unit CRS
mi
from
San Juan,
Click here to add this to my saved trials
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome
Status: Enrolling
Updated:  12/2/2015
NYU School of Medicine
mi
from
New York, NY
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome
Status: Enrolling
Updated: 12/2/2015
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome
Status: Enrolling
Updated:  12/2/2015
The Lung Institute at University of Cape Town
mi
from
Cape Town,
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome
Status: Enrolling
Updated: 12/2/2015
The Lung Institute at University of Cape Town
mi
from
Cape Town,
Click here to add this to my saved trials
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
An Open-label, Multiple Dose, Cross-over Study to Evaluate the Steady-state Pharmacokinetic Parameters of Nevirapine Extended Release Tablets in HIV-1 Infected Children, With an Optional Extension Phase
Status: Enrolling
Updated:  12/2/2015
1245.25.10068 Boehringer Ingelheim Investigational Site
mi
from
Washington,
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
An Open-label, Multiple Dose, Cross-over Study to Evaluate the Steady-state Pharmacokinetic Parameters of Nevirapine Extended Release Tablets in HIV-1 Infected Children, With an Optional Extension Phase
Status: Enrolling
Updated: 12/2/2015
1245.25.10068 Boehringer Ingelheim Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
An Open-label, Multiple Dose, Cross-over Study to Evaluate the Steady-state Pharmacokinetic Parameters of Nevirapine Extended Release Tablets in HIV-1 Infected Children, With an Optional Extension Phase
Status: Enrolling
Updated:  12/2/2015
Boehringer Ingelheim Investigational Site
mi
from
Philadelphia, PA
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
An Open-label, Multiple Dose, Cross-over Study to Evaluate the Steady-state Pharmacokinetic Parameters of Nevirapine Extended Release Tablets in HIV-1 Infected Children, With an Optional Extension Phase
Status: Enrolling
Updated: 12/2/2015
Boehringer Ingelheim Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
An Open-label, Multiple Dose, Cross-over Study to Evaluate the Steady-state Pharmacokinetic Parameters of Nevirapine Extended Release Tablets in HIV-1 Infected Children, With an Optional Extension Phase
Status: Enrolling
Updated:  12/2/2015
1100.1518.2605 Boehringer Ingelheim Investigational Site
mi
from
Francistown,
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
An Open-label, Multiple Dose, Cross-over Study to Evaluate the Steady-state Pharmacokinetic Parameters of Nevirapine Extended Release Tablets in HIV-1 Infected Children, With an Optional Extension Phase
Status: Enrolling
Updated: 12/2/2015
1100.1518.2605 Boehringer Ingelheim Investigational Site
mi
from
Francistown,
Click here to add this to my saved trials
Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV
Atherosclerotic Risk and Response to Exercise Intervention in HIV+ Children
Status: Enrolling
Updated:  12/4/2015
University of Miami, Department of Pediatrics, Division of Clinical Research, Batchelor Children's Research Institute
mi
from
Miami, FL
Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV
Atherosclerotic Risk and Response to Exercise Intervention in HIV+ Children
Status: Enrolling
Updated: 12/4/2015
University of Miami, Department of Pediatrics, Division of Clinical Research, Batchelor Children's Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
New Haven, CT
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Washington,
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Boston, MA
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Jackson, MS
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Las Vegas, NV
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
New York, NY
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Durham, NC
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Philadelphia, PA
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Providence, RI
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Providence, RI
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Austin, TX
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Beverly Hills, CA
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Fountain Valley, CA
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
Los Angeles, CA
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
San Diego, CA
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated:  12/7/2015
GSK Investigational Site
mi
from
San Francisco, CA
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
A Phase III Study to Demonstrate the Antiviral Activity and Safety of Dolutegravir in HIV-1 Infected Adult Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Status: Enrolling
Updated: 12/7/2015
GSK Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials